SCHEMBL8086323

SCHEMBL8086323

C=C(Nc1cccc(Cl)c1)c1ccc(-n2cccn2)nc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.54
HPGD P15428 2/20 0.54
LMNA P02545 1/20 0.50
ALDH1A1 P00352 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
CXCR4 P61073 1/20 0.45
SIRT2 Q8IXJ6 1/20 0.45
SIRT1 Q96EB6 1/20 0.45
SIRT3 Q9NTG7 1/20 0.45
PARP1 P09874 1/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2C19 P33261 2/20 0.44
CYP2D6 P10635 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NLRP3 Q96P20 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13930567 0.86 KDM4E (0.72) KDM4EHPGDLMNAALDH1A1RXFP1
SCHEMBL8081787 0.79 CNR1 (0.48) KDM4EHPGDLMNAALDH1A1KMT2A
SCHEMBL8086591 0.76 CNR2 (0.56) HPGDLMNAALDH1A1KMT2AMEN1
SCHEMBL24221933 0.70 KMT2A (0.46) HPGDLMNAALDH1A1KMT2AMEN1
SCHEMBL28050524 0.70 MEN1 (0.56) KDM4EHPGDLMNAALDH1A1KMT2A
SCHEMBL22925970 0.70 LMNA (0.57) KDM4EHPGDLMNAALDH1A1RXFP1
SCHEMBL8071307 0.69 MAPKAPK2 (0.46) LMNAALDH1A1KMT2AMEN1NPC1
SCHEMBL8082051 0.69 HCAR3 (0.49) KDM4EALDH1A1KMT2AMEN1P4HTM
SCHEMBL12978173 0.68 KDM4E (0.71) KDM4EHPGDLMNAALDH1A1RXFP1
SCHEMBL29425707 0.68 LMNA (1.00) KDM4EHPGDLMNAALDH1A1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009016088-A1 THE USE OF BENZAMIDE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2009-02-05 WO disclosed